Open AccessCorticosteroid Treatment for Melanoma-Associated Retinopathy
Author(s) -
C. Jacobzone,
C. Cochard-Marianowski,
I. Kupfer,
S. Benchekroun Bettembourg,
Yves Dordain,
L. Misery,
Béatrice Cochener,
B. Sassolas
Publication year - 2004
Publication title -
archives of dermatology
Language(s) - English
Resource type - Journals
eISSN - 1538-3652
pISSN - 0003-987X
DOI - 10.1001/archderm.140.10.1258
Subject(s) - medicine , melanoma , retinopathy , retinal detachment , visual acuity , uveitis , dermatology , surgery , retinal , ophthalmology , diabetes mellitus , cancer research , endocrinology
Visual disturbance in the course of melanoma is rare. Specific localized metastases and drug toxic effects are frequently the cause. Recognition of a retinopathy raises several questions when the diagnosis of melanoma-associated retinopathy (MAR) can be confirmed. Descriptions of such patients in dermatologic literature are rare and deserve attention because therapeutic decisions are mandatory.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom